by Erowid.org
- DEPRENYL
- Deprenyl Prevents Protein Oxidation
- Rodriguez-Gomez JA; Venero JL; Vizuete ML; Cano J
- Brain Res Mol Brain Res, Vol 46 (No. 1-2) June 1997, 31-38
- Brain Res Mol Brain Res, Vol 46 (No. 1-2) June 1997, 31-38
- Deprenyl And 'Excess Mortality'
- Riggs JE
- Clin Neuropharmacol, Vol 20 (No. 3) June 1997, 276-278
- Clin Neuropharmacol, Vol 20 (No. 3) June 1997, 276-278
- Monoamine oxidase B inhibitors. Current status and future potential
- CNS Drugs (New Zealand), Vol 6 (No. 3) 1996, 217-236
- The neuroprotective and neuronal rescue effects of (-)-deprenyl
- Magyar K; Szende B; Lengyel J; Tarczali J; Szatm´ary I
- J Neural Transm Suppl, Vol 52():1998;109-23
- J Neural Transm Suppl, Vol 52():1998;109-23
- Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP subjects not requiring levodopa
- Parkinson Study Group
- Ann Neurol, Vol 39(No 1): Jan 1996; 29-36
- Ann Neurol, Vol 39(No 1): Jan 1996; 29-36
- (-)Deprenyl (selegiline), a catecholaminergic activity enhancer (CAE) substance acting in the brain
- Knoll J
- Pharmacol Toxicol, Vol 82(No 2):Feb 1998;57-66
- Pharmacol Toxicol, Vol 82(No 2):Feb 1998;57-66